Kats-Ugurlu G - Search Results

1

False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (¹⁸F-FDOPA-PET) performed for imaging of neuroendocrine tumors.

Berends AMA, Kerstens MN, Bolt JW, Links TP, Korpershoek E, de Krijger RR, Walenkamp AME, Noordzij W, van Etten B, Kats-Ugurlu G, Brouwers AH, van der Horst-Schrivers ANA. Berends AMA, et al. Eur J Endocrinol. 2018 Aug;179(2):125-133. doi: 10.1530/EJE-18-0321. Epub 2018 Jun 6. Eur J Endocrinol. 2018. PMID: 29875288

2

Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancer.

Bisschop C, Tjalma JJ, Hospers GA, Van Geldere D, de Groot JW, Wiegman EM, Van't Veer-Ten Kate M, Havenith MG, Vecht J, Beukema JC, Kats-Ugurlu G, Mahesh SV, van Etten B, Havenga K, Burgerhof JG, de Groot DJ, de Vos Tot Nederveen Cappel WH. Bisschop C, et al. Ann Surg Oncol. 2015 Feb;22(2):552-6. doi: 10.1245/s10434-014-3996-8. Epub 2014 Aug 26. Ann Surg Oncol. 2015. PMID: 25155395

3

Niacin (Vitamin B3) Supplementation in Patients with Serotonin-Producing Neuroendocrine Tumor.

Bouma G, van Faassen M, Kats-Ugurlu G, de Vries EG, Kema IP, Walenkamp AM. Bouma G, et al. Neuroendocrinology. 2016;103(5):489-94. doi: 10.1159/000440621. Epub 2015 Sep 4. Neuroendocrinology. 2016. PMID: 26335390

4

Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging ¹⁸F-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer.

Beukinga RJ, Hulshoff JB, Mul VEM, Noordzij W, Kats-Ugurlu G, Slart RHJA, Plukker JTM. Beukinga RJ, et al. Radiology. 2018 Jun;287(3):983-992. doi: 10.1148/radiol.2018172229. Epub 2018 Mar 14. Radiology. 2018. PMID: 29533721

5

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.

Borggreve AS, Mook S, Verheij M, Mul VEM, Bergman JJ, Bartels-Rutten A, Ter Beek LC, Beets-Tan RGH, Bennink RJ, van Berge Henegouwen MI, Brosens LAA, Defize IL, van Dieren JM, Dijkstra H, van Hillegersberg R, Hulshof MC, van Laarhoven HWM, Lam MGEH, van Lier ALHMW, Muijs CT, Nagengast WB, Nederveen AJ, Noordzij W, Plukker JTM, van Rossum PSN, Ruurda JP, van Sandick JW, Weusten BLAM, Voncken FEM, Yakar D, Meijer GJ; PRIDE study group. Borggreve AS, et al. BMC Cancer. 2018 Oct 20;18(1):1006. doi: 10.1186/s12885-018-4892-6. BMC Cancer. 2018. PMID: 30342494 Free PMC article. Clinical Trial.

6

Reversal of secondary protein-losing enteropathy after surgical revision of a jejunal Roux-en-Y loop in a patient after liver transplantation.

Holvast A, Kats-Ugurlu G, Bodewes FAJA, de Kleine RHJ, Porte RJ, Brouwers AH, van der Doef HPJ. Holvast A, et al. Am J Transplant. 2019 Jul;19(7):2116-2121. doi: 10.1111/ajt.15354. Epub 2019 Apr 2. Am J Transplant. 2019. PMID: 30868732 Free article.

7

Quantitative Profiling of Platelet-Rich Plasma Indole Markers by Direct-Matrix Derivatization Combined with LC-MS/MS in Patients with Neuroendocrine Tumors.

van Faassen M, Bouma G, de Hosson LD, Peters MAM, Kats-Ugurlu G, de Vries EGE, Walenkamp AME, Kema IP. van Faassen M, et al. Clin Chem. 2019 Nov;65(11):1388-1396. doi: 10.1373/clinchem.2019.305359. Epub 2019 Sep 24. Clin Chem. 2019. PMID: 31551315

8

Neuroendocrine tumours and their microenvironment.

de Hosson LD, Takkenkamp TJ, Kats-Ugurlu G, Bouma G, Bulthuis M, de Vries EGE, van Faassen M, Kema IP, Walenkamp AME. de Hosson LD, et al. Cancer Immunol Immunother. 2020 Aug;69(8):1449-1459. doi: 10.1007/s00262-020-02556-1. Epub 2020 Apr 8. Cancer Immunol Immunother. 2020. PMID: 32270230 Free PMC article.

9

Effect of Extending the Original CROSS Criteria on Tumor Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A National Multicenter Cohort Analysis.

Wang HH, de Heer EC, Hulshoff JB, Kats-Ugurlu G, Burgerhof JGM, van Etten B, Plukker JTM, Hospers GAP; Dutch Upper Gastrointestinal Cancer Audit (DUCA) Group. Wang HH, et al. Ann Surg Oncol. 2021 Jul;28(7):3951-3960. doi: 10.1245/s10434-020-09372-y. Epub 2020 Nov 28. Ann Surg Oncol. 2021. PMID: 33249520 Free PMC article.

10

Clinical selection strategy for and evaluation of intra-operative brachytherapy in patients with locally advanced and recurrent rectal cancer.

Dijkstra EA, Mul VEM, Hemmer PHJ, Havenga K, Hospers GAP, Kats-Ugurlu G, Beukema JC, Berveling MJ, El Moumni M, Muijs CT, van Etten B. Dijkstra EA, et al. Radiother Oncol. 2021 Jun;159:91-97. doi: 10.1016/j.radonc.2021.03.010. Epub 2021 Mar 17. Radiother Oncol. 2021. PMID: 33741470 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page